Search Results - "ROBBINS, JOHN B"

Refine Results
  1. 1

    Toward a new vaccine for pertussis by Robbins, John B., Schneerson, Rachel, Kubler-Kielb, Joanna, Keith, Jerry M., Trollfors, Birger, Vinogradov, Evgeny, Shiloach, Joseph

    “…To overcome the limitations of the current pertussis vaccines, those of limited duration of action and failure to induce direct killing of Bordetella pertussis…”
    Get full text
    Journal Article
  2. 2

    The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines by Thiem, Vu Dinh, Lin, Feng-Ying C, Canh, Do Gia, Son, Nguyen Hong, Anh, Dang Duc, Mao, Nguyen Duc, Chu, Chiayung, Hunt, Steven W, Robbins, John B, Schneerson, Rachel, Szu, Shousun C

    Published in Clinical and Vaccine Immunology (01-05-2011)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates by Robbins, John B, Kubler-Kielb, Joanna, Vinogradov, Evguenii, Mocca, Christopher, Pozsgay, Vince, Shiloach, Joseph, Schneerson, Rachel

    “…Shigellosis, an enteric disease, is on the World Health Organization's priority prevention list. In one study, the Shigella sonnei O-specific polysaccharide…”
    Get full text
    Journal Article
  4. 4

    Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice by Pozsgay, Vince, Kubler-Kielb, Joanna, Schneerson, Rachel, Robbins, John B

    “…Endemic and epidemic shigellosis, an acute invasive disease of the lower intestines, afflicts millions of people worldwide with an estimated one million…”
    Get full text
    Journal Article
  5. 5

    Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus by Biesova, Zuzana, Miller, Mark A, Schneerson, Rachel, Shiloach, Joseph, Green, Kim Y, Robbins, John B, Keith, Jerry M

    Published in Vaccine (19-10-2009)
    “…Abstract Production of influenza vaccines requires a minimum of 6 months after the circulating strain is isolated and the use of infectious viruses. The…”
    Get full text
    Journal Article
  6. 6

    Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2 by Robbins, John B, Schneerson, Rachel, Xie, Guilin, Åke-Hanson, Lars, Miller, Mark A

    “…We reviewed the literature that is the basis for our proposal that (2→8)-α-Neu5Ac conjugates will be safe and effective vaccines for Group B meningococci…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease by Pozsgay, Vince, Kubler-Kielb, Joanna, Coxon, Bruce, Marques, Adriana, Robbins, John B., Schneerson, Rachel

    Published in Carbohydrate research (06-09-2011)
    “…Borrelia burgdorferi is the etiological agent for Lyme disease (LD), the most common vector borne disease in the United States. There is no human vaccine…”
    Get full text
    Journal Article
  9. 9

    Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25 by Kubler-Kielb, Joanna, Majadly, Fathy, Wu, Yimin, Narum, David L, Guo, Chunyan, Miller, Louis H, Shiloach, Joseph, Robbins, John B, Schneerson, Rachel

    “…Malaria is a leading cause of morbidity and mortality, estimated to cause >1 million childhood deaths annually. Plasmodium falciparum causes the most severe…”
    Get full text
    Journal Article
  10. 10

    Safety and Immunogenicity of Escherichia coli O157 O-Specific Polysaccharide Conjugate Vaccine in 2–5-Year-Old Children by Ahmed, Amina, Li, Jianpin, Shiloach, Yossi, Robbins, John B., Szu, Shousun C.

    Published in The Journal of infectious diseases (15-02-2006)
    “…Background. Escherichia coli O157:H7 causes severe enteritis and hemolytic-uremic syndrome, mostly in young children and older adults. Similar to the case with…”
    Get full text
    Journal Article
  11. 11

    Phase 1 Study of a Recombinant Mutant Protective Antigen of Bacillus anthracis by Bellanti, Joseph A, Lin, Feng-Ying C, Chu, Chiayung, Shiloach, Joseph, Leppla, Stephen H, Benavides, German A, Karpas, Arthur, Moayeri, Mahtab, Guo, Chunyan, Robbins, John B, Schneerson, Rachel

    Published in Clinical and Vaccine Immunology (01-02-2012)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A mAb Recognizing a Surface Antigen of Mycobacterium tuberculosis Enhances Host Survival by Teitelbaum, Rachel, Glatman-Freedman, Aharona, Chen, Bing, Robbins, John B., Unanue, Emil, Casadevall, Arturo, Bloom, Barry R.

    “…Murine mAbs reactive with the surface of Mycobacterium tuberculosis were assayed for their ability to affect the course of infection in mice challenged with…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children by Lin, Feng Ying C, Lanh, Mai Ngoc, Thanh, Tran Cong, Bryla, Dolores A, Van Bay, Phan, Chu, Chiayung, Ho, Vo Anh, Schiloach, Joseph, Robbins, John B, Schneerson, Rachel, Szu, Shousun C

    Published in The New England journal of medicine (02-10-2003)
    “…To the Editor: The limitations of the three licensed typhoid vaccines that precluded their use in children younger than five years old have been overcome by a…”
    Get full text
    Journal Article
  16. 16

    Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component by Kubler-Kielb, Joanna, Vinogradov, Evgeny, Hu, Haijing, Leppla, Stephen H, Robbins, John B, Schneerson, Rachel

    “…Bacillus anthracis is a spore-forming bacterium that causes anthrax in humans and in other mammals. The glycoprotein BclA (Bacillus collagen-like protein of…”
    Get full text
    Journal Article
  17. 17

    Additional Conjugation Methods and Immunogenicity of Bacillus anthracis Poly-γ-D-Glutamic Acid-Protein Conjugates by Kubler-Kielb, Joanna, Liu, Teh-Yung, Mocca, Christopher, Majadly, Fathy, Robbins, John B, Schneerson, Rachel

    Published in Infection and Immunity (01-08-2006)
    “…The capsule of Bacillus anthracis, composed of poly-γ-D-glutamic acid (γDPGA), is an essential virulence factor of B. anthracis. The capsule inhibits innate…”
    Get full text
    Journal Article
  18. 18

    Evaluation of Serum Bactericidal Antibody Assays for Haemophilus influenzae Serotype a by Rouphael, Nadine G, Satola, Sarah, Farley, Monica M, Rudolph, Karen, Schmidt, Daniel S, Gomez-de-León, Patricia, Robbins, John B, Schneerson, Rachel, Carlone, George M, Romero-Steiner, Sandra

    Published in Clinical and Vaccine Immunology (01-02-2011)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  19. 19

    Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice by Farzam, Nahid, Ramon-Saraf, Reut, Banet-Levi, Yonit, Lerner-Geva, Liat, Ashkenazi, Shai, Kubler-Kielb, Joanna, Vinogradov, Evgeny, Robbins, John B., Schneerson, Rachel

    Published in Vaccine (05-09-2017)
    “…Shigella flexneri (S. flexneri) 6 has emerged as an important cause of shigellosis. Our efficacy study of Shigella sonnei and S. flexneri 2a O-specific…”
    Get full text
    Journal Article
  20. 20